This content is machine translated Esophageal Cancer Early diagnosis and individual follow-up Esophageal cancer occurs on average at age 60. It is the sixth leading cause of cancer-related death. Robotic surgery allows more radical procedures under optimal visibility – for a better…
View Post 11 min This content is machine translated Ewing's Sarcoma Management of the second most common primary malignant bone tumor Therapy of choice for Ewing’s sarcoma includes neoadjuvant chemotherapy, tumor resection, and postoperative chemotherapy with/without radiotherapy. In this context, interdisciplinary management at an appropriate center is of crucial importance.
View Post 8 min This content is machine translated CNS Lymphoma Induction and consolidation – which agents, regimens and targets? Therapy for primary CNS lymphoma has evolved greatly in recent years. The life expectancy of patients has increased. Methotrexate remains the basis of all induction therapies. In consolidation, the situation…
View Post 6 min This content is machine translated Mucosal melanomas of the head and neck region Rarer but more aggressive than cutaneous melanomas Primary mucosal melanoma of the head and neck is rare. However, it behaves much more aggressively compared to cutaneous malignant melanoma. Corresponding leading symptoms should be the reason for a…
View Post 5 min This content is machine translated Current therapy 2014 Surgical update on colon and rectal cancer. In the case of colorectal carcinoma, surgery is still the only way to cure the disease. Primary therapy of colon carcinoma consists of oncologic resection of the tumor-bearing bowel segment.…
View Post 6 min This content is machine translated Radiological clarification in lung carcinoma When are which instruments used? Many lung cancers are still diagnosed at a late or advanced and thus symptomatic stage. Based on recent study data, various professional societies have made positive recommendations for lung screening,…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
View Post 2 min This content is machine translated Bronchus carcinoma Dawn in non-small cell lung cancer? At the beginning of every medical advance is the intention and hope of the researcher to understand a problem in order to then bring it to a solution. Hope is…
